Literature DB >> 36261230

Tuberculosis diagnosis and management in the public versus private sector: a standardised patients study in Mumbai, India.

Jishnu Das1, Madhukar Pai2, Benjamin Daniels1, Daksha Shah3, Ada T Kwan4, Ranendra Das5, Veena Das6, Varsha Puri3, Pranita Tipre3, Upalimitra Waghmare3, Mangala Gomare3, Padmaja Keskar3.   

Abstract

BACKGROUND: There are few rigorous studies comparing quality of tuberculosis (TB) care in public versus private sectors.
METHODS: We used standardised patients (SPs) to measure technical quality and patient experience in a sample of private and public facilities in Mumbai.
RESULTS: SPs presented a 'classic, suspected TB' scenario and a 'recurrence or drug-resistance' scenario. In the private sector, SPs completed 643 interactions. In the public sector, 164 interactions. Outcomes included indicators of correct management, medication use and client experience. Public providers used microbiological testing (typically, microscopy) more frequently, in 123 of 164 (75%; 95% CI 68% to 81%) vs 223 of 644 interactions (35%; 95% CI 31% to 38%) in the private sector. Private providers were more likely to order chest X-rays, in 556 of 639 interactions (86%; 95% CI 84% to 89%). According to national TB guidelines, we found higher proportions of correct management in the public sector (75% vs 35%; (adjusted) difference 35 percentage points (pp); 95% CI 25 to 46). If X-rays were considered acceptable for the first case but drug-susceptibility testing was required for the second case, the private sector correctly managed a slightly higher proportion of interactions (67% vs 51%; adjusted difference 16 pp; 95% CI 7 to 25). Broad-spectrum antibiotics were used in 76% (95% CI 66% to 84%) of the interactions in public hospitals, and 61% (95% CI 58% to 65%) in private facilities. Costs in the private clinics averaged rupees INR 512 (95% CI 485 to 539); public facilities charged INR 10. Private providers spent more time with patients (4.4 min vs 2.4 min; adjusted difference 2.0 min; 95% CI 1.2 to 2.9) and asked a greater share of relevant questions (29% vs 43%; adjusted difference 13.7 pp; 95% CI 8.2 to 19.3).
CONCLUSIONS: While the public providers did a better job of adhering to national TB guidelines (especially microbiological testing) and offered less expensive care, private sector providers did better on client experience. © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ.

Entities:  

Keywords:  cross-sectional survey; infections, diseases, disorders, injuries; public health; tuberculosis

Mesh:

Substances:

Year:  2022        PMID: 36261230      PMCID: PMC9582305          DOI: 10.1136/bmjgh-2022-009657

Source DB:  PubMed          Journal:  BMJ Glob Health        ISSN: 2059-7908


  48 in total

1.  The quality of medical advice in low-income countries.

Authors:  Jishnu Das; Jeffrey Hammer; Kenneth Leonard
Journal:  J Econ Perspect       Date:  2008

2.  Quality and Accountability in Health Care Delivery: Audit-Study Evidence from Primary Care in India.

Authors:  Jishnu Das; Alaka Holla; Aakash Mohpal; Karthik Muralidharan
Journal:  Am Econ Rev       Date:  2016-12

Review 3.  Antimicrobial resistance in Mycobacterium tuberculosis: mechanistic and evolutionary perspectives.

Authors:  Sebastian M Gygli; Sonia Borrell; Andrej Trauner; Sebastien Gagneux
Journal:  FEMS Microbiol Rev       Date:  2017-05-01       Impact factor: 16.408

Review 4.  Fluoroquinolones are associated with delayed treatment and resistance in tuberculosis: a systematic review and meta-analysis.

Authors:  Tun-Chieh Chen; Po-Liang Lu; Chun-Yu Lin; Wei-Ru Lin; Yen-Hsu Chen
Journal:  Int J Infect Dis       Date:  2010-12-30       Impact factor: 3.623

5.  Durations and Delays in Care Seeking, Diagnosis and Treatment Initiation in Uncomplicated Pulmonary Tuberculosis Patients in Mumbai, India.

Authors:  Nerges Mistry; Sheela Rangan; Yatin Dholakia; Eunice Lobo; Shimoni Shah; Akshaya Patil
Journal:  PLoS One       Date:  2016-03-28       Impact factor: 3.240

6.  India's plan to eliminate tuberculosis by 2025: converting rhetoric into reality.

Authors:  Madhukar Pai; Soumyadeep Bhaumik; Soumitra S Bhuyan
Journal:  BMJ Glob Health       Date:  2017-03-20

7.  Such a long journey: What health seeking pathways of patients with drug resistant tuberculosis in Mumbai tell us.

Authors:  Aruna Bhattacharya Chakravarty; Sheela Rangan; Yatin Dholakia; Sonu Rai; Swaran Kamble; Tejaswi Raste; Sanchi Shah; Shimoni Shah; Nerges Mistry
Journal:  PLoS One       Date:  2019-01-17       Impact factor: 3.240

8.  Simulated patients and their reality: An inquiry into theory and method.

Authors:  Veena Das; Benjamin Daniels; Ada Kwan; Vaibhav Saria; Ranendra Das; Madhukar Pai; Jishnu Das
Journal:  Soc Sci Med       Date:  2021-11-25       Impact factor: 5.379

9.  Comparing the Quality of Primary Care between Public and Private Providers in Urban China: A Standardized Patient Study.

Authors:  Min Su; Zhongliang Zhou; Yafei Si; Sean Sylvia; Gang Chen; Yanfang Su; Scott Rozelle; Xiaolin Wei
Journal:  Int J Environ Res Public Health       Date:  2021-05-11       Impact factor: 3.390

10.  Antibiotic overuse in the primary health care setting: a secondary data analysis of standardised patient studies from India, China and Kenya.

Authors:  Jishnu Das; Madhukar Pai; Giorgia Sulis; Benjamin Daniels; Ada Kwan; Sumanth Gandra; Amrita Daftary
Journal:  BMJ Glob Health       Date:  2020-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.